大型B细胞淋巴瘤的突变异质性:来自对联活检的见解
Ditte Stampe Hersby1, Lone Schejbel2, Marie Fredslund Breinholt2,3
1Department of Hematology, Rigshospitalet, Copenhagen, Denmark. ditte.stampe.hersby@regionh.dk.
Annals of hematology
|December 7, 2024
概括
大型B细胞淋巴瘤 (LBCL) 在患者中显示出显著的遗传变异. 多部位活检对于充分了解瘤演变和指导治疗决策至关重要.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 血液学 血液学 血液学
背景情况:
- 大型B细胞淋巴瘤 (LBCL) 具有相当大的临床和分子多样性.
- 评估LBCL异质性需要全面的基因组数据,但单个活检的充分性尚不清楚.
- 了解患者内变异是准确分类和治疗的关键.
研究的目的:
- 在个别患者中调查LBCL突变格局的空间和时间变化.
- 确定单位活检是否足以进行LBCL.的综合基因组分析.
- 分析LBCL的突变特征如何从诊断到复发之间发生变化.
主要方法:
- 从30名LBCL患者的诊断和/或复发时从不同的解剖部位收集了配对活检.
- 使用定制的59基因小组对所有样本进行了下一代测序 (NGS).
- 在空间和时间上不同的活检之间对突变特征进行比较分析.
主要成果:
- 在配对活检之间观察到致病突变的显著差异 (33%在诊断时,50%在复发时).
- 随着活检间隔的延长,突变异质性增加,克隆消失,新的克隆出现.
- 经常检测到TP53突变的 extranodal网站,有时仅在复发活检.
结论:
- 多部位活检揭示了LBCL显著的空间和时间突变异质性.
- 活检对之间的突变差异发生在所有阶段,从诊断到复发.
- 在复发时重复活检是必要的,以捕捉完整的基因改变的完整范围,以有效管理.
相关概念视频
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...